These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stability of an extemporaneously prepared thalidomide suspension. Kraft S; Johnson CE; Tyler RP Am J Health Syst Pharm; 2012 Jan; 69(1):56-8. PubMed ID: 22180553 [TBL] [Abstract][Full Text] [Related]
3. Stability of norfloxacin in an extemporaneously prepared oral liquid. Johnson CE; Price J; Hession JM Am J Health Syst Pharm; 2001 Apr; 58(7):577-9. PubMed ID: 11296605 [TBL] [Abstract][Full Text] [Related]
4. Stability of dolasetron in two oral liquid vehicles. Johnson CE; Wagner DS; Bussard WE Am J Health Syst Pharm; 2003 Nov; 60(21):2242-4. PubMed ID: 14619116 [TBL] [Abstract][Full Text] [Related]
5. Stability of extemporaneously prepared rifaximin oral suspensions. Cober MP; Johnson CE; Lee J; Currie K Am J Health Syst Pharm; 2010 Feb; 67(4):287-9. PubMed ID: 20133533 [TBL] [Abstract][Full Text] [Related]
6. Stability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 days. Johnson CE; Cober MP Am J Health Syst Pharm; 2007 Nov; 64(22):2356-8. PubMed ID: 17989445 [TBL] [Abstract][Full Text] [Related]
8. Stability of levamisole oral solutions prepared from tablets and powder. Chiadmi F; Lyer A; Cisternino S; Toledano A; Schlatter J; Ratiney R; Fontan JE J Pharm Pharm Sci; 2005 Aug; 8(2):322-5. PubMed ID: 16124942 [TBL] [Abstract][Full Text] [Related]
9. Stability of an extemporaneously prepared clopidogrel oral suspension. Skillman KL; Caruthers RL; Johnson CE Am J Health Syst Pharm; 2010 Apr; 67(7):559-61. PubMed ID: 20237383 [TBL] [Abstract][Full Text] [Related]
10. Stability evaluation of 7 % chloral hydrate syrup contained in mono and multi-dose bottles under room and refrigeration conditions. Bustos-Fierro C; Olivera ME; Manzo PG; Jiménez-Kairuz ÁF Farm Hosp; 2013; 37(1):4-9. PubMed ID: 23461494 [TBL] [Abstract][Full Text] [Related]
11. Stability of extemporaneously prepared glycopyrrolate oral suspensions. Cober MP; Johnson CE; Sudekum D; Penprase K Am J Health Syst Pharm; 2011 May; 68(9):843-5. PubMed ID: 21515869 [TBL] [Abstract][Full Text] [Related]
12. Stability of 10-mg/mL and 50-mg/mL ketamine oral solutions. Ancedy D; Sebti M; Postaire M; Vidal F; Cisternino S; Schlatter J Am J Health Syst Pharm; 2021 Apr; 78(9):825-831. PubMed ID: 33611378 [TBL] [Abstract][Full Text] [Related]
13. Stability of extemporaneously prepared moxifloxacin oral suspensions. Hutchinson DJ; Johnson CE; Klein KC Am J Health Syst Pharm; 2009 Apr; 66(7):665-7. PubMed ID: 19299374 [TBL] [Abstract][Full Text] [Related]
14. Stability of an extemporaneously prepared tadalafil suspension. Pettit RS; Johnson CE; Caruthers RL Am J Health Syst Pharm; 2012 Apr; 69(7):592-4. PubMed ID: 22441791 [TBL] [Abstract][Full Text] [Related]
15. Stability of melatonin in an extemporaneously compounded sublingual solution and hard gelatin capsule. Haywood A; Burrell A; Breda Kv; George R; Testa C; Norris R Int J Pharm Compd; 2009; 13(2):170-4. PubMed ID: 23970011 [TBL] [Abstract][Full Text] [Related]
16. Stability of a flavored formulation of acetylcysteine for oral administration. Siden R; Johnson CE Am J Health Syst Pharm; 2008 Mar; 65(6):558-61. PubMed ID: 18319502 [TBL] [Abstract][Full Text] [Related]
17. Stability of an extemporaneously compounded baclofen oral liquid. Johnson CE; Hart SM Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961 [TBL] [Abstract][Full Text] [Related]
18. Stability of an extemporaneously prepared alcohol-free phenobarbital suspension. Cober MP; Johnson CE Am J Health Syst Pharm; 2007 Mar; 64(6):644-6. PubMed ID: 17353574 [TBL] [Abstract][Full Text] [Related]
19. Stability of extemporaneously prepared oxandrolone oral suspensions. Johnson CE; Cober MP; Hawkins KA; Julian JD Am J Health Syst Pharm; 2011 Mar; 68(6):519-21. PubMed ID: 21378300 [TBL] [Abstract][Full Text] [Related]
20. Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus. Fohl AL; Johnson CE; Cober MP Am J Health Syst Pharm; 2011 Jan; 68(1):69-72. PubMed ID: 21164069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]